Immuron Ltd Files 6-K Report

Ticker: IMRN · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateApr 10, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-k, company-update

TL;DR

Immuron Ltd filed a 6-K, likely an update, check for details.

AI Summary

On April 10, 2025, Immuron Limited filed a Form 6-K to report a public notice. The filing does not contain specific financial figures or new material information beyond the reporting of this notice.

Why It Matters

This filing indicates Immuron Limited is providing an update or announcement to the SEC, which could contain information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a routine report of a public notice and does not contain new financial data or significant operational changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report a public notice published by Immuron Limited for the month of April 2025.

What is Immuron Limited's principal executive office address?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Does Immuron Limited file annual reports under Form 20-F or Form 40-F?

Immuron Limited indicates it files annual reports under cover of Form 20-F.

Is Immuron Limited furnishing information under Rule 12g3-2(b)?

No, Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

What is the SIC code for Immuron Limited?

The Standard Industrial Classification (SIC) code for Immuron Limited is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding Immuron Ltd (IMRN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing